U.S. markets closed

BioSig Technologies, Inc. (BSGM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6675+0.0275 (+4.30%)
At close: 04:00PM EDT
0.6793 +0.01 (+1.77%)
After hours: 04:23PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close0.6400
Bid0.6451 x 1400
Ask0.6999 x 1000
Day's Range0.6250 - 0.6700
52 Week Range0.5000 - 4.1010
Avg. Volume276,325
Market Cap29.914M
Beta (5Y Monthly)1.28
PE Ratio (TTM)N/A
EPS (TTM)-0.9120
Earnings DateAug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for BSGM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BioSig Technologies, Inc.
    Analyst Report: Boston Scientific CorporationBoston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
    Fair Value
    Economic Moat
    10 days agoMorningstar
View more
  • GlobeNewswire

    BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module

    Company to introduce the most advanced iteration of its signal processing technology at Cleveland Clinic’s Global EP Summit 2022, a world-class leadership symposiumWestport, CT, Sept. 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the release of PURE E

  • GlobeNewswire

    Taglich Brothers Initiates Coverage of BioSig Technologies, Inc.

    NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces it has initiated coverage of BioSig Technologies, Inc. (NASDAQ: BSGM). BioSig Technologies, Inc., headquartered in Westport CT, is a medical technology company that is in the early stages of commercializing an FDA–cleared product, the PURE EP™ System. This system helps electrophysiologists treat patients suffering from complex arrhythmias with a procedure called cardiac catheter ablation. The complete 18-page report is

  • Zacks

    The Zacks Analyst Blog Highlights ShockWave Medical, CheckCap and Biosig Technologies

    ShockWave Medical, CheckCap and Biosig Technologies are part of The Zacks top Analyst Blog.